BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9709967)

  • 1. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss.
    Dandona P; Weinstock R; Thusu K; Abdel-Rahman E; Aljada A; Wadden T
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2907-10. PubMed ID: 9709967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity.
    Tsigos C; Kyrou I; Chala E; Tsapogas P; Stavridis JC; Raptis SA; Katsilambros N
    Metabolism; 1999 Oct; 48(10):1332-5. PubMed ID: 10535400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.
    Miyazaki Y; Pipek R; Mandarino LJ; DeFronzo RA
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):88-94. PubMed ID: 12532159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects.
    Straczkowski M; Kowalska I; Nikolajuk A; Adamska A; Karolczuk-Zarachowicz M; Karczewska-Kupczewska M; Kozlowska A; Gorska M
    Cardiovasc Diabetol; 2006 Jun; 5():14. PubMed ID: 16803616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered tumor necrosis factor alpha release from mononuclear cells of obese reproductive-age women during hyperglycemia.
    González F; Minium J; Rote NS; Kirwan JP
    Metabolism; 2006 Feb; 55(2):271-6. PubMed ID: 16423637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation.
    Dandona P; Mohanty P; Ghanim H; Aljada A; Browne R; Hamouda W; Prabhala A; Afzal A; Garg R
    J Clin Endocrinol Metab; 2001 Jan; 86(1):355-62. PubMed ID: 11232024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum soluble tumor necrosis factor-alpha receptor 2 is elevated in obesity but is not related to insulin sensitivity: a study in identical twins discordant for obesity.
    Rönnemaa T; Pulkki K; Kaprio J
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2728-32. PubMed ID: 10946872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of tumor necrosis factor alpha and leptin in obesity and insulin resistance].
    Sun Q; Yang GH; Wang H
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):514-7. PubMed ID: 16080843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can changes in plasma insulin concentration explain the variability in leptin response to weight loss in obese women with normal glucose tolerance?
    Carantoni M; Abbasi F; Azhar S; Schaaf P; Reaven GM
    J Clin Endocrinol Metab; 1999 Mar; 84(3):869-72. PubMed ID: 10084563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of weight loss on serum concentrations of FAS and tumour necrosis factor alpha in obese women.
    Zahorska-Markiewicz B; Olszanecka-Glinianowicz M; Janowska J; Kocełak P
    Endokrynol Pol; 2008; 59(1):18-22. PubMed ID: 18335396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum growth hormone-binding protein in obesity: effect of a short-term, very low calorie diet and diet-induced weight loss.
    Rasmussen MH; Ho KK; Kjems L; Hilsted J
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1519-24. PubMed ID: 8636361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of ghrelin is related to estimated insulin sensitivity in obese children.
    Krohn K; Boczan C; Otto B; Heldwein W; Landgraf R; Bauer CP; Koletzko B
    Int J Obes (Lond); 2006 Oct; 30(10):1482-7. PubMed ID: 16801928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher unacylated ghrelin and insulin sensitivity following dietary restriction and weight loss in obese humans.
    Barazzoni R; Gortan Cappellari G; Zanetti M; Klaus KA; Semolic A; Johnson ML; Nair KS
    Clin Nutr; 2021 Feb; 40(2):638-644. PubMed ID: 32641220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients.
    Kopp HP; Kopp CW; Festa A; Krzyzanowska K; Kriwanek S; Minar E; Roka R; Schernthaner G
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1042-7. PubMed ID: 12714437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.
    Vgontzas AN; Trakada G; Bixler EO; Lin HM; Pejovic S; Zoumakis E; Chrousos GP; Legro RS
    Metabolism; 2006 Aug; 55(8):1076-82. PubMed ID: 16839844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.
    Holte J; Bergh T; Berne C; Wide L; Lithell H
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2586-93. PubMed ID: 7673399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss.
    McLaughlin T; Stühlinger M; Lamendola C; Abbasi F; Bialek J; Reaven GM; Tsao PS
    J Clin Endocrinol Metab; 2006 May; 91(5):1896-900. PubMed ID: 16507636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of TNF-alpha and soluble TNF-alpha receptors in obesity.
    Zahorska-Markiewicz B; Janowska J; Olszanecka-Glinianowicz M; Zurakowski A
    Int J Obes Relat Metab Disord; 2000 Nov; 24(11):1392-5. PubMed ID: 11126333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum concentrations of tumor necrosis factor TNFalpha and its soluble receptors in obese women with diabetes type 2 and without additional disease].
    Olszanecka-Glinianowicz M; Waluszek-Kończakowska I; Zahorska-Markiewicz B; Janowska J
    Endokrynol Pol; 2005; 56(2):174-8. PubMed ID: 16335686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of weight loss on insulin secretion and in vivo insulin sensitivity in obese diabetic and non-diabetic subjects.
    Escalante-Pulido M; Escalante-Herrera A; Milke-Najar ME; Alpizar-Salazar M
    Diabetes Nutr Metab; 2003; 16(5-6):277-83. PubMed ID: 15000438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.